Outcomes of Robotic-Assisted Prostatectomy: A Multi-Center Retrospective Study

Robotic-assisted prostatectomy has become an increasingly popular approach for the surgical treatment of prostate cancer, offering advantages such as precision, minimally invasive access, and potentially shorter recovery times compared to traditional open prostatectomy. This multi-center retrospective study aims to evaluate the clinical outcomes of robotic-assisted prostatectomy (RARP) across different institutions, with a focus on key parameters such as operative time, blood loss, complication rates, oncologic outcomes, and postoperative recovery. Data was collected from a cohort of patients who underwent RARP for prostate cancer at multiple medical centers over a specified period, analyzing both short-term and long-term outcomes. The study examines the impact of surgeon experience, patient demographics (e.g., age, BMI, comorbidities), and tumor characteristics (e.g., stage, Gleason score) on surgical results. Key findings suggest that RARP is associated with lower blood loss, shorter hospital stays, and faster recovery times compared to open prostatectomy, with comparable oncologic outcomes in terms of margin rates and biochemical recurrence. The study also evaluates complications, including urinary incontinence, erectile dysfunction, and lymphocele formation, highlighting strategies for minimizing these risks. Furthermore, the review discusses the economic aspects of robotic-assisted surgery, including the initial costs of robotic systems, cost-effectiveness over the long term, and the potential for reduced hospital readmissions. This study provides robust evidence supporting the effectiveness of robotic-assisted prostatectomy as a safe and efficient approach for the treatment of prostate cancer, with positive outcomes across multiple centers. It also emphasizes the importance of continued training, standardized protocols, and further prospective studies to refine the technique and optimize patient outcomes. In conclusion, robotic-assisted prostatectomy offers significant benefits in terms of recovery and complication rates, making it a preferred option for many prostate cancer patients. However, patient selection and institutional resources remain important considerations for ensuring the best possible surgical outcomes.